Health Canada drug identification number

DIN 00402699 — APO-CARBAMAZEPINE 200 MG

APO-CARBAMAZEPINE is a tablet of Carbamazepine marketed by APOTEX INC. The full Carbamazepine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00402699
Brand name
APO-CARBAMAZEPINE
Active ingredient
Carbamazepine
Strength
200 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
APOTEX INC
Health Canada status
DORMANT
Drug class
Anticonvulsant (iminostilbene derivative)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Carbamazepine products

DINBrandStrengthFormManufacturerStatus
00504742 MAZEPINE 200 MG TABLET BIOMED PHARMA DORMANT
02541238 MINT-CARBAMAZEPINE 200 MG TABLET MINT PHARMACEUTICALS INC MARKETED
02261839 SANDOZ-CARBAMAZEPINE CR 200 MG TABLET (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED
02261847 SANDOZ-CARBAMAZEPINE CR 400 MG TABLET (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED
02367394 TARO-CARBAMAZEPINE 100 MG SUSPENSION TARO PHARMACEUTICALS INC MARKETED
02244403 TARO-CARBAMAZEPINE CHEWABLE TABLETS 100 MG TABLET (CHEWABLE) TARO PHARMACEUTICALS INC MARKETED
02244404 TARO-CARBAMAZEPINE CHEWABLE TABLETS 200 MG TABLET (CHEWABLE) TARO PHARMACEUTICALS INC MARKETED
00010405 TEGRETOL 200 MG TABLET NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
00773611 TEGRETOL CR 200 MG TABLET (EXTENDED-RELEASE) NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
00755583 TEGRETOL CR 400 MG TABLET (EXTENDED-RELEASE) NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
02194333 TEGRETOL SUSPENSION 100 MG SUSPENSION NOVARTIS PHARMACEUTICALS CANADA INC MARKETED
00782718 TEVA-CARBAMAZEPINE 200 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.